Cart
sales@molnova.com
Nav1.7 inhibitor
CAS No. 1355631-24-1
Nav1.7 inhibitor( —— )
Catalog No. M33035 CAS No. 1355631-24-1
Nav1.7 inhibitor is a Nav1.7 inhibitor for research in the field of pain and anesthesia.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 211 | Get Quote |
|
| 5MG | 330 | Get Quote |
|
| 25MG | 1049 | Get Quote |
|
| 50MG | 1371 | Get Quote |
|
| 100MG | 1791 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameNav1.7 inhibitor
-
NoteResearch use only, not for human use.
-
Brief DescriptionNav1.7 inhibitor is a Nav1.7 inhibitor for research in the field of pain and anesthesia.
-
DescriptionNav1.7 inhibitor (compound II), a sulfonamide, is a potent Nav1.7 inhibitor. Nav1.7 inhibitor has the potential for a wide range of disorders, particularly pain.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetSodium Channel
-
RecptorSodium Channel
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1355631-24-1
-
Formula Weight426.68
-
Molecular FormulaC15H11Cl3FNO4S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : ≥ 100 mg/mL (234.37 mM )
-
SMILESO=C(NS(=O)(=O)C)C=1C=C(Cl)C(=CC1F)COC2=CC=C(Cl)C(Cl)=C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Alan Daniel Brown, et al. Preparation of sulfonamide derivatives as Nav1.7 inhibitors. Patent WO2012007868A2.
molnova catalog
related products
-
L(-)-sorbose
L(-)-sorbose is a ketose belonging to the group of sugars known as monosaccharides.
-
Bulleyaconi cine A
Bulleyaconitine A is an analgesic and antiinflammatory drug isolated from Aconitum plants; has several potential targets, including voltage-gated Na+ channels.
-
Butyl 4-aminobenzoat...
Butamben is a long-duration local anesthetic used for the treatment of chronic pain.
